Elevidys’ Age-Restricted Indication Not Negotiable, CBER’s Peter Marks Told Sarepta

CBER Director Peter Marks told Sarepta his decision on an age-limited indication was not up for negotiation. • Source: Shutterstock

More from Drug Review Profiles